2024 ESC Guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy?
Eur Heart J Cardiovasc Pharmacother
.
2025 Feb 8;11(1):7-9.
doi: 10.1093/ehjcvp/pvae084.
Authors
Cian P McCarthy
1
,
Rosa Maria Bruno
2
3
,
John W McEvoy
4
5
6
,
Rhian M Touyz
7
8
Affiliations
1
D ivision of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
2
Paris Cardiovascular Research Centre - PARCC, Université Paris Cité, INSERM U970 Team 7, Paris, France.
3
Hopital Europeen Georges Pompidou, Pharmacology and Hypertension Unit, Assistance Publique-Hopitaux de Paris, Paris, France.
4
Cardiology Department, Galway University Hospital and University of Galway School of Medicine, Galway, Ireland.
5
National Institute for Prevention and Cardiovascular Health, Galway, Ireland.
6
Johns Hopkins Ciccarone Centre for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD, USA.
7
Department of Medicine, McGill University, Montreal, Canada.
8
Research Institute of the McGill University Health Centre, McGill University, Montreal, Canada.
PMID:
39439212
PMCID:
PMC11805683
DOI:
10.1093/ehjcvp/pvae084
No abstract available
Grants and funding
K23 HL167659/HL/NHLBI NIH HHS/United States
K23HL167659/HL/NHLBI NIH HHS/United States